Cellectar Biosciences announced today it is the recipient of a $2.3 million Fast-Track SBIR grant. According to a release, the money from the National Cancer Institute will help fund development of the…

Cellectar Biosciences CEO Jim Caruso was chosen to present at the Rodman & Renshaw 17th Annual Global Investment Conference, taking place Sept. 10 in New York City, the organization announced recently. “The…

Cellectar Biosciences named Jim Caruso to be its new President and CEO, the company announced today. “(Jim) brings a level of energy and commitment, combined with his significant industry experience that…